Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Italo Tempera

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Mbio|July 14, 2025
Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenomeLeonardo Josué Castro-Muñoz, Davide Maestri, Leena Yoon, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Histone Variant H2A.Z Cooperates with EBNA1 to Maintain Epstein-Barr Virus Latent EpigenomeJosue Leonardo Castro-Muñoz, Davide Maestri, Leena Yoon, et al.
Disease Models & Mechanisms|August 3, 2016
Alterations in nuclear structure promote lupus autoimmunity in a mouse modelNamrata Singh, Duncan B Johnstone, Kayla A Martin, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I programLaura A Murray-Nerger, Davide Maestri, Xiang Liu, et al.
Infectious Agents and Cancer|October 13, 2007
Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progressionStefania Mattiussi, Italo Tempera, Giulia Matusali, et al.
Chemmedchem|March 3, 2011
Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cellsLuciana Mosca, Dante Rotili, Italo Tempera, et al.
Journal of Virology|July 7, 2018
PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency TypeLena N Lupey-Green, Lisa B Caruso, Jozef Madzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 17, 2016
Novel STIM1-dependent control of Ca2+ clearance regulates NFAT activity during T-cell activationElsie Samakai, Robert Hooper, Kayla A Martin, et al.
Cell Host & Microbe|August 21, 2012
An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactionsAaron Arvey, Italo Tempera, Kevin Tsai, et al.
Journal of Virology|November 22, 2013
Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding siteHorng-Shen Chen, Kayla A Martin, Fang Lu, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Mbio|July 14, 2025
Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenomeLeonardo Josué Castro-Muñoz, Davide Maestri, Leena Yoon, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Histone Variant H2A.Z Cooperates with EBNA1 to Maintain Epstein-Barr Virus Latent EpigenomeJosue Leonardo Castro-Muñoz, Davide Maestri, Leena Yoon, et al.
Disease Models & Mechanisms|August 3, 2016
Alterations in nuclear structure promote lupus autoimmunity in a mouse modelNamrata Singh, Duncan B Johnstone, Kayla A Martin, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I programLaura A Murray-Nerger, Davide Maestri, Xiang Liu, et al.
Infectious Agents and Cancer|October 13, 2007
Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progressionStefania Mattiussi, Italo Tempera, Giulia Matusali, et al.
Chemmedchem|March 3, 2011
Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cellsLuciana Mosca, Dante Rotili, Italo Tempera, et al.
Journal of Virology|July 7, 2018
PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency TypeLena N Lupey-Green, Lisa B Caruso, Jozef Madzo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 17, 2016
Novel STIM1-dependent control of Ca2+ clearance regulates NFAT activity during T-cell activationElsie Samakai, Robert Hooper, Kayla A Martin, et al.
Cell Host & Microbe|August 21, 2012
An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactionsAaron Arvey, Italo Tempera, Kevin Tsai, et al.
Journal of Virology|November 22, 2013
Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding siteHorng-Shen Chen, Kayla A Martin, Fang Lu, et al.
Pageof 7